in barcelona, jeffrey lazarus is the head of the research group at barcelona institute for global health the associate professor of law and technology. welcome to the program, thank you for your time with us. jeffrey, over to you first. i know that you said we need to focus on providing explanation and guidance to combat false information. spotify has since said it's working to add warnings to any podcast that discusses covid-19. for you, is that a satisfactory response by spotify? >> i think it's a start to provide verify information, evidence-based information. but i think we need to distinguish between what spotify calls as controversial compares to what is simply wrong and false. there are different kinds of information, there's misinformation and disinformation, and when spotify allows information that is directly dangerous, like arguing that vaccines for covid-19 are not safe, or to take unproven treatments, then i think that that passes a certain line. >> courtney, spotify has said that in the past that it has removed more than 20,000 podcast episodes that covered -- cover covid-1

l, a. institute for technology law and policy, and barcelona, jeffrey lazarus. he's the head of the health systems research group at barcelona institute for global health. and in the judge city of ma, stressed, catalina, go on to associate professor of law and technology at trust university. welcome to the program. thanks so much for your time with us, jeffrey. over to you 1st, i know that you said that we need to focus on providing explanations and guidance to combat false information. so spotify, as we've been reporting, has since that it's working to add advisory warnings to any podcast that discusses cobra. 1900 for you, is that a satisfactory response by salt spotify? i think it's a start to provide verified information, evidence based information. but i think we need to distinguish between what spotify calls as controversial compared to what is simply wrong and false. there are different kinds of information. there's misinformation, there's this information, and when to modify allows information that is directly dangerous, like, arguing that vaccines for c

towards a new vaccine. jeffrey lazarus is head of the health systems research group at the barcelona institute for global health, and he's told us more about the initial stages of these vaccine trials. this is a phase one trial. so this is the earliest stage after proof of concept, the 1st few people received from the vaccine just a couple of days ago. so this will be a multi year process. but given again the rapid success with them, the coven, 19 vaccines using m r and a technology. and that after 30 years, we had a malaria vaccine approved last year for the 1st time. obviously expectations are going to be very high. what we know is that the m r and a technology was not both, frankly, very well thought of or successful until the curb 19 vaccine. so, so now that we've seen that, that technology can work there, madana and pfizer actually going to be trying to develop more than 20 different vaccines. there's been so much attention given h i v aids in recent years. both in terms of vaccines and treatments and issues related now to quality of life that you know that the focus on an h i. v vaccine

use public transport. jeffrey lazarus is the head of the house systems research school by the barcelona institute for global health. he says, easing all restrictions that once doesn't make sense. i think its a bad move to list all restrictions. i understand the population is tired and many are thrilled that all restrictions are being removed, but it gives a false sense of security. i think that could have been a more gradual reduction in, in lifting. i think denmark, in that sense to setting a bad president, it's basically politics over public health. they could have kept face masks on, at least in public transportation. i don't think many people would be complaining about that. i do think it's a lot about the politics and being, being able to say, you know, we were the 1st to do this. we were and we were the government in power, but i think it's sending the wrong message to that population sir. cases are higher than ever, and hospitalizations actually going up. the numbers in the intensive care units is, is not going up. so that's a good sign. but i mean, you're hospitalizations are going up, wh

towards a new vaccine. jeffrey lazarus as head of the health systems research group at the barcelona institute for global health. he told us more above the initial stages of these vaccine trials. this is a phase one trial. so this is the earliest stage after proof of concept, the 1st few people received from the vaccine just a couple of days ago. so this will be a multi year process, but given again the rapid success with them, the coven, 19 vaccines using m r and a technology. and that after 30 years, we had a malaria vaccine approved last year for the 1st time. obviously expectations are going to be very high. what we know is that the emerson, a technology was not both frankly, very well thought of or successful until the curb 1900 vaccine. so, so now that we've seen that, that technology can work there, madana and pfizer actually going to be trying to develop more than 20 different vaccines. there's been so much attention given to h. i v. aids in recent years, both in terms of vaccines and treatments and issues related now to quality of life that you know that the focus on an h i. v vaccine

, i want to bring in jeffrey lazarus, he's head of the health systems research group at the barcelona institute for global health. good, happy with us again on al jazeera and the phrasing of this announcement concentrates on the fact that this is a new direction for vaccine design and testing rather than focusing on any, an ultimate outcomes. why is a new direction so significant is still significant because h a v vaccines have been failing for over 2 decades. i remember being at the aides conference in 2008 when we expected a vaccine to be successful. and again, it failed. so given the success of the m r n, a vaccines against corporate 19, this is, this is fantastic news. how could this affect the lives of people living with h o v, assuming that it is a success? well, it won't have much of an effect for those with h i v, but the vaccine will prevent new infections. and right now, almost $700000.00 people die every year of age related diseases. so this is a major infectious disease and a vaccine would be a complete game changer in the country is most affected, which are largely in sub saharan a